2013 American Transplant Congress

Lack of Association between Infection and Increased Sensitization in Kidney Transplant Recipients

A. Aljanabi, L. Kayler, A. Colovai, P. Masiakos, M. Ajaimy, E. Akalin

Lack of Clinical Factors Increasing Quantitative Interstitial Fibrosis after Renal Transplantation under a Lower Target Trough Strategy of Tacrolimus

N. Komine, S. Satoh, K. Numakura, M. Saito, T. Inoue, S. Narita, Y. Miura, N. Tsuchiya, H. Kagaya, M. Miura, T. Habuchi

Laparoendoscopic Single Site Donor Nephrectomy Offers Better Cosmesis, and Comparable Surgical Outcomes to Conventional Retroperitoneoscopic Surgery

M. Miura, Y. Itoh, S. Tsuchihashi, M. Hattori, J. Gotoh, T. Tamaki

Laparoscopic Sleeve Gastrectomy in Obese Renal Transplant Candidates

T. Diwan, C. Freeman, R. Alloway, A. Rikes-Shields, G. Moglishetty, A. Govil, M. Cardi, R. Munda, S. Shah, M. Cuffy, F. Paterno, S. Woodle

Late after Lung Transplantation Many Patients Have Donor-Specific HLA Antibodies (DSA) and High DSA Levels Appear To Be Associated with Poor Outcomes

L. Baxter-Lowe, J. Singer, S. Hays, J. Kukreja, J. Golden, L. Leard

Late Antibody-Mediated Rejection (AMR) after Kidney Transplantation

M. Martina, F. Oppenheimer, I. Revuelta, J. Campistol Planas, M. Sole, J. Cid, F. Diekmann

Late Extra-Hepatic Biliary Strictures after Liver Transplantation: First Evidence of Association with Pre-Existing Donor Specific Antibodies

S. Loeb, E. Schadde, B. Ruesi-Elsener, P. Dutkowski, C. Pierre Alain, B. Jens

Late Versus Early Biliary Complications after Liver Transplantation

V. Gupta, N. Onaca, M. Saeed, A. Dabous, M. Asolati, R. Ruiz, P. Kim, G. Testa, R. Goldstein, G. Klintmalm

LCP-Tacro Improves TAC-Induced Tremors: Preliminary Analysis of Switching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): An Exploratory Study

A. Langone, R. Gedaly, S. Steinberg, T. Shah, V. Nigro

Learning Curve of ECMO in DCD (Better the Devil You Know?)

I. Abboud, D. Viglietti, F. Gaudez, F. Fieux, F. Roussin, C. Antoine, D. Glotz

Leflunomide Confers Protection to the Post-Ischemic Kidney Via Inhibition of GADD153 Expression and Inflammation

A. Ghaffari, M. Masoumy, J. Liu, B. Babak

Levels of IL-33 and Soluble IL-33 Receptor (sST2) Distinguish Acute Rejection from Enteritis in Small Bowel Transplant Recipients

R. Fischer, L. Mathews, Y. Sun, D. Mercer, H. Turnquist

Levothyroxine Therapy Prior to Brain Death Declaration Increases the Number of Solid Organ Donations

B. Joseph, H. Aziz, V. Pandit, N. Kulvatunyou, A. Tang, J. Wynne, T. O'Keeffe, R. Friese, G. Vercruysse, L. Gries, D. Green, P. Rhee, R. Gruessner

Likelihood of Improving or Maintaining Renal Function in Recipients of Extended-Criteria Donor Kidneys over Five Years with Belatacept or CsA (BENEFIT-EXT Long-Term Extension Study)

J. Grinyo, Y. Vanrenterghem, A. Durrbach, M. Rial, B. Charpentier, A. Matas, F. Lehner, L. Pupim, M. Coffey, J. Pestana

Likelihood of Improving or Maintaining Renal Function over Five Years with Belatacept or CsA: Insights from the BENEFIT Long-Term Extension Study

J. Grinyo, A. Durrbach, L. Rostaing, B. Bresnahan, J. Helderman, K. Rice, F. Vincenti, L. Pupim, M. Coffey, J. Pestana

Limits of Paired Donation – Who Doesn’t Get Transplanted?, The

H. Li, M. Stegall, K. Reddy, E. Casey, P. Dean, R. Heilman, F. Cosio, H. Khamash, M. Prieto

LineageProfiler: A Novel Informatics Tool for Unraveling Transplant Injury

N. Salomonis, M. Naesens, T. Sigdel, M. Sarwal

Lipocalin-2 in Serum Samples of Recipients Following Liver Transplantation as Predictive and Monitoring Marker for Acute Allograft Rejection

N. Vallant, H. Maier, M. Kofler, P. Schumpp, S. Schneeberger, R. Oellinger, J. Pratschke, F. Aigner

Live-Time Imaging of Chemotactic Responses in Activated T Cells Demonstrate Novel Exploratory Patterns of Migration towards Chemokines

N. Jain, I. Wong, E. Wong, L. Boneschansker, A. Aranyosi, D. Briscoe, D. Irimia

Liver Allografts Do Not Always Protect from Kidney Allograft Rejection in Sensitized Recipients of Simultaneous Liver-Kidney Transplants

O. Bestard, J. Cruzado, O. Taco, L. Lladó, E. Melilli, J. Fabregat, S. Gil-Vernet, A. Rafecas, J. Grinyó

Liver and Multi-Organ Exchange

J. Dickerson, T. Sandolm

Liver B Cells Exhibit Pro-Inflammatory Activity, Secrete Less IL-10, and Are More Potent Inducers of Hepatic DC Maturation Than Those from Secondary Lymphoid Tissue

H. Zhang, A. Thomson

Liver Biopsy as Rejection Criteria in Living Donor Liver Transplant: Analysis of 94 Cases

W. Al-hamoudi, F. Abaalkhail, H. Almanea, H. Elsiesy, A. Hashim, M. Al-sofayan, H. Albahili, D. Broering, M. Al sebayel

Liver Grafts from Anti-HBc Positive Donors for Anti-HBc Negative Recipients in Liver Transplantation Using Combined Antiviral Prophylaxis

A. Brandl, P. Stolzlechner, S. Eschertzhuber, F. Aigner, I. Graziadei, W. Vogel, S. Schneeberger, J. Pratschke, R. Öllinger

Liver May Not Protect Against Kidney Rejection in Simultaneous Liver-Kidney Transplantation (SLK), The

J. Krupp, K. Nilles, L. Gallon, J. Levitsky

Liver Preservation with Machine Perfusion under Full Oxygenation Using a New Cell-Free Oxygen-Carrier Solution

P. Fontes, W. Marsh, R. Lopez, K. Soltys, V. Scott, A. van der Plaats, W. Light, S. Shiva, M. Minnervinni, A. Demetris

Liver Retransplantation in HIV-Infected Patients: A Multicenter and Multinational Cohort Study

M. Gastaca, F. Agüero, S. Peter, G. Paolo, R. Jüergen, A. Kosh, G. Christian, B. Laura Alicia, M. Fernando, M. Marta, R. Antonio, M. Jose, the FIPSE/NIH HIVTR/NEAT023 Investigators

Liver Transplant (OLT) Length of Stay (LOS) 2000-2010: An Analysis of the UNOS/OPTN Database

D. Kelly, J. Hammel, J. Fung

Liver Transplant for NASH: We Need To Spare the Nephron!

C. Jordan, N. Pilch, D. Taber, H. Meadows, J. Fleming, A. Mardis, K. Morbitzer, C. Makowski, J. McGillicuddy, C. Bratton, A. Lin, P. Baliga, K. Chavin

Liver Transplant Outcomes for Primary Sclerosing Cholangitis: Role of Ethnicity and IBD

N. Kemmer, G. Neff, E. Cece, E. Parkinson, A. Alsina

Liver Transplant Program Quality Index Which Accounts for Transplant Rate; the Power of Numbers!, A

C. Rochon, A. Lally, M. Brown, P. Sheiner

Liver Transplantation (LT) in Patients Receiving Renal Replacement Therapy (RRT): Predicting Renal Recovery and Post-Transplant Futility

V. Agopian, J. Baber, A. Dhillon, H. Petrowsky, A. Zarrinpar, F. Kaldas, H. Yersiz, D. Farmer, J. Hiatt, R. Busuttil

Liver Transplantation for Neonatal Hemochromatosis: Analysis of the UNOS Database

S. Sheflin-Findling, R. Annunziato, R. Ragusa, J. Chu, N. Kerkar, R. Arnon

Liver Transplantation for Polycystic Liver Disease: A 20-Year Experience

J. Baber, V. Agopian, J. Hiatt, R. Busuttil

Liver Transplantation for Severe Hepatopulmonary Syndrome

J. Lohlun, C. Mingmalairak, J. Lake, R. Kandaswamy, W. Payne, T. Pruett, S. Chinnakotla

Liver Transplantation from Donors with past History of Malignancies: A Single Center Experience

T. Benkö, S. Radünz, M. Banysch, F. Saner, A. Paul, J. Treckmann

Liver Transplantation Versus Liver Resection in the Treatment of Hepatocellular Carcinoma: A Meta-Analysis

Liver Transplantation: Do Senescence and Autophagy Modulate the Development of Chronic Pathology

J. Brain, E. Thompson, D. Jones, A. Burt, J. Kirby

Liver Transportation Time Model and Comparison with Cold Ischemia Time

S. Gentry, E. Chow, C. Wickliffe, A. Massie, T. Leighton, J. Snyder, A. Israni, B. Kasiske, D. Segev

Living Donor Conversion Rate as a Quality Measure for Kidney Transplant Programs

E. Woodle, B. Woodle, A. Girnita, M. Cuffy, S. Shah, J. Schold, J. Gill

Living Donor Kidney Transplantation in the Pediatric Population: Risk Factors for Adverse Outcomes

A. Walther, A. Coots, M. Alonso, J. Goebel, G. Tiao, J. Nathan

Living Donor Liver Transplantation for High MELD Score Patients

H. Chou, C. Lee, R. Soong, T. Wu, T. Wu, K. Chan, W. Lee

Living Kidney Donor Consent: Compliance with CMS & OPTN Requirements

C. Thiessen, Y. Kim, R. Formica, M. Bia, S. Kulkarni

Locally-Delivered CD4+CD25highFoxp3+ Regulatory T Cells Combined with Systemic KRP203 Therapy Induces Tolerance to Islet Allografts

C. Baum, M. Khattar, R. Deng, B. Kahan, P. Schroder, T. Phan, L. Rutzky, S. Stepkowski

Long Term (5-Year) Outcomes Using Subcutaneous Alemtuzumab for Induction in Highly-HLA-Sensitized (HS) Kidney Transplant Recipients

G. Chang, A. Vo, J. Choi, J. Kahwaji, R. Villicana, A. Peng, S. Jordan

Long Term Clinical Outcome of Liver Transplant Recipients Who Successfully Withdrawn Immunosuppression, The

T. Manzia, R. Angelico, L. Toti, L. Fazzolari, L. Tariciotti, D. Sforza, M. Manuelli, V. Tognoni, A. Di Giorgio, G. Tisone

Long Term Outcomes and Quality of Life of Live Liver Donors. A Single Center Experience

V. Humphreville, T. Pruett, J. Lake, R. Kandaswamy, W. Payne, S. Chinnakotla, D. Radosevich

Long Term Outcomes of Highly-HLA Sensitized (PRA>80%) (HS) Patients Receiving Desensitization with IVIG or IVIG + Rituximab: A Retrospective, Single-Center Analysis

A. Vo, J. Choi, J. Kahwaji, A. Peng, R. Villicana, R. Najjar, S. Jordan

Long Term Outcomes of Incidentally Discovered Hepatocellular Carcinoma

K. Thudi, A. Humar, A. Tevar, M. Gajendran, S. Malik

Long Term Outcomes of Treatment for Vascular Complication Following Living Donor Liver Transplantation: The Efficacy of Stent Placement

S. Mizuno, K. Yamakado, A. Tanemura, N. Kuriyama, I. Ohsawa, Y. Azumi, M. Kishiwada, M. Usui, H. Sakurai, M. Tabata, H. Sakuma, S. Isaji

Long Term Outcomes of Young (< 18 Years) Kidney Donors: A Matched Cohort Analysis

D. MacDonald, S. Jackson, A. Matas, R. Spong, A. Kukla, H. Ibrahim

Long Term Survival of PEGylated Murine Allogenic Islets Using Short Course Immunomodulation

J. Giraldo, C. Fotino, H. Rengifo, R. Molano, C. Ricordi, A. Pileggi, C. Stabler

Long Term Transplant Outcome of Hepatitis B Virus and Hepatitis Delta Virus Coinfection

W. Al-hamoudi, S. Ali, H. Elsiesy, A. Hashim, B. Hegab, A. Bendahmash, H. Albahili, D. Broering, M. Al sebayel, M. Al-sofayan, F. Abaalkhail

Long-Range, CIS-Regulatory Architecture of the IL-2 and IL-21 Multi-Locus Region

P. Mehra, A. Wells

Long-Term Assessment of Function in Patients Completing the Spare-the-Nephron Study with a Functioning Graft

M. Weir, STN Extension Study Group

Long-Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results from the Long-Term Extension (LTE) of the Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression Trial (BENEFIT) Study

C. Larsen, F. Vincenti, J. Grinyo, K. Rice, S. Steinberg, L. Gaite, M. Moal, L. Pupim, L. Rostaing

Long-Term Calcineurin Inhibitor (CNI) and Corticosteroid (CS) Avoidance Using Belatacept: The CTOT-10 Experience

K. Newell, R. Mannon, A. Mehta, S. Tomlanovich, Y. Morrison, D. Ikle, J. Goodman, S. Mehta, N. Bridges, P. Stock, C. Larsen

Long-Term Cyclosporine Treatment Reduces the STAT3-Inhibitory Effect by Decreasing GRIM-19 Expression

S. Lim, K. Doh, L. Jin, S. Piao, S. Heo, B. Chung, C. Yang

Long-Term Exposure to Belatacept in Recipients of Extended Criteria Donor Kidneys

S. Florman, J. Pestana, M. Rial, L. Rostaing, J. Grinyo, Y. van Renterghem, F. Muhlbacher, L. Pupim, B. Charpentier

Long-Term Graft Survival Retrieved from Donors after Cardiac Death Have Been Significantly Improved in These Two Decades Although the Procurement Technique Remains Unchanged during the Three Decades

M. Kusaka, Y. Kubota, N. Fukami, M. Takenaka, H. Sasaki, R. Shiroki, T. Kenmochi, K. Hoshinaga

Long-Term Impact of a Pancreas Graft on a Previously Transplanted Kidney

A. Gruessner, R. Gruessner

Long-Term Impact of CMV Infection on the Allograft and on Patient Survival in Renal Transplant Patients with Protocol Biopsies

U. Erdbruegger, I. Scheffner, M. Mengel, A. Schwarz, H. Haller, W. Gwinner

Long-Term Impact of Recipient and Donor Weight on Simultaneous Pancreas / Kidney (SPK) Graft Function

A. Gruessner, R. Gruessner

Long-Term Outcomes after Liver Transplantation for Wilson Disease: A Single-Center Experience

J. Lai, M. Schilsky, T. Schiano, A. Shirsat, J. Chu, R. Arnon

Long-Term Outcomes Following Acute Rejection in Kidney Transplant Recipients: An ANZDATA Analysis

P. Clayton, S. McDonald, G. Russ, S. Chadban

Long-Term Outcomes of Liver Transplant Patients with HIV-1 Infection: a 14-Year Single-Center Clinical Experience

S. Yamamoto, R. Schwarcz, O. Weiland, A. Oksanen, A. Wernersson, G. Söderdahl, A. Sönnerborg, B. Ericzon

Long-Term Outcomes of Older Adults after Liver Transplantation in the MELD Era

M. Malinis, S. Chen, H. Allore, V. Quagliarello

Long-Term Persistence of Recipient MHC Class-II Antigen Following Allogeneic Bone Marrow Transplantation

T. Brennan, L. Lin, Y. Yang

Long-Term Quality of Life Following Living Kidney Donation

N. Siparsky, O. Glotzer, T. Singh, M. Gallichio, D. Conti

Long-Term Risk of ESRD Attributable to Live Kidney Donation: Matching with Healthy Non-Donors

A. Muzaale, A. Massie, J. Wainright, M. McBride, M. Wang, D. Segev

Long-Term Safety and Effectiveness of Inhibitors of the Mammalian Target of Rapamycin in De Novo Kidney Transplantation: 10 Years of a Single Center Experience

M. Paula, P. Hannun, C. Felipe, H. Tedesco, J. Medina- Pestana

Long-Term Satisfaction with Life after Living Kidney Donation: A RELIVE Study

E. Messersmith, B. Gillespie, B. Hong, C. Jacobs, S. Taler, S. Jowsey, R. Merion, A. Leichtman, C. Beil, C. Gross, the RELIVE Study Group

Longer Duration of Pretransplant Dialysis Is a Risk Factor for Death after Kidney Transplantation Also in the Current Era

I. Helanterä, K. Salmela, L. Kyllönen, P. Koskinen, C. Grönhagen-Riska, P. Finne

Loss of Deceased Donor Livers to Technical and Systems Failures: A Difficult Determination with Possibly Easier Solutions

M. Kluger, A. Kluger, B. Samstein, J. Guarrera, T. Kato, J. Emond, D. Cherqui

Loss of Pediatric Kidney Grafts during the "High-Risk Age Window": Insights from Liver Recipients

K. Van Arendonk, B. Orandi, B. Boyarsky, N. James, P. Colombani, J. Magee, D. Segev

Low Affinity Memory CD8+ T Cells Are Potently Alloreactive Against High Affinity Antigen in a Model of T Cell Receptor Cross-Reactive Heterologous Immunity

S. Krummey, C. Larsen, M. Ford

Low Birth Weight and Risk of Proteinuria in Former Kidney Donors

D. MacDonald, S. Jackson, A. Kukla, R. Spong, N. Issa, A. Matas, H. Ibrahim

Low GFR after Kidney Donation Is Not Chronic Kidney Disease

L. de Vries, H. Tent, J. Sanders, S. Hofker, S. Bakker, G. Navis

Low Level Pre-Transplant DSAs Are Frequent but Are Not Associated with a Rejection Diagnosis in Pancreas Transplant Biopsies

A. Asderakis, D. Singleton, J. Witherspoon, D. Chapman, M. Stephens, D. Elker, E. Ablorsu, D. Griffiths

Low-Dose Cyclosporine (CsA) Plus Mycophenolate Mofetil (MMF) and Prednisolone (Pred) Triple Immunosuppressive Protocol in Renal Transplantation

H. Xiang, W. Xue, P. Tian, X. Ding, X. Pan, H. Yan, J. Hou, X. Feng, X. Tian, C. Ding

Low-Molecular-Weight Heparin Dosing and Monitoring in Solid Organ Transplant Recipients

M. Moten, A. Gaber, D. Putney, S. Patel

Lower Serum Magnesium 1-Year Posttranplantation Is Associated with Decreased Graft Survival in Renal Transplant Recipients

C. Nihei, I. Marques, L. Lima, R. Maia, A. Seguro, E. David-Neto

Lung Allograft Tolerance in Non-Human Primates Via Establishment of Stable Mixed Hematopoietic Chimerism

S. Lee, A. Aoyama, M. Tonsho, S. Boskovic, Y. Yamada, O. Nadazdin, R. Smith, R. Colvin, A. Cosimi, J. Madsen, T. Kawai, G. Benichou, J. Allan

Lung Cancer Following Kidney Transplant: Incidence, Risk Factors, and Outcomes

Y. Guo, T. Ng, P. Morrissey

Lung Recipients with Post-Transplant Lung Cancer and Comparison with Other Organ Recipients

R. Desai, D. Collett, T. Evans, J. Neuberger

Lung Transplant with Allografts from Donors with a History of Smoking: A Nationwide Analysis of Usage and Outcomes

A. Castleberry, P. Speicher, M. Worni, L. Snyder, A. Osho, R. Pietrobon, S. Palmer, R. Davis, M. Hartwig

Lymphotoxin Receptor Signaling Regulates Tolerogenic Functions of Fibroblastic Reticular Cells in the Lymph Node

Y. Nakayama, J. Bromberg

Lymphotoxin Regulates Treg Entry into the Lymph Node

C. Brinkman, J. Bromberg